Annual report pursuant to Section 13 and 15(d)

REVENUES (Tables)

v3.20.4
REVENUES (Tables)
12 Months Ended
Dec. 31, 2020
REVENUES  
Schedule of revenues disaggregated by category

Revenues disaggregated by category were as follows (in thousands):

Year Ended December 31,

2020

    

2019

    

2018

Product sales:

Gross product sales

$

76,470

$

53,082

$

16,953

Discounts and allowances

(14,774)

 

(9,310)

 

(3,006)

Product sales, net

$

61,696

$

43,772

$

13,947

Revenues from collaborations:

License revenues

40,358

$

8,696

30,562

Development milestones

2,100

 

5,500

 

Research and development services and others

4,467

 

1,320

 

Total revenues from collaborations

46,925

15,516

30,562

Total revenues

$

108,621

$

59,288

$

44,509

Customer revenues (as a percentage of gross revenues)

The following table summarizes revenues from each of our customers who individually accounted for 10% or more (wherein * denotes less than 10%) of our gross revenues (as a percentage of gross revenues):

Year Ended December 31,

2020

    

2019

2018

Grifols

41%

*

ASD Healthcare and Oncology Supply

30%

37%

17%

McKesson Specialty Care Distribution Corporation

23%

30%

11%

Kissei

*

69%

Schedule of product revenue allowance and reserve categories

The following tables summarize the activities in chargebacks, discounts and fees, government and other rebates and returns during the years ended December 31, 2020 and 2019 (in thousands):

Chargebacks,

Government

Discounts and

and Other

Fees

Rebates

Returns

Total

Balance at January 1, 2020

    

$

1,293

 

$

1,801

$

238

$

3,332

Provision related to current period sales

8,149

4,231

950

13,330

Adjustment related to prior period sales

(75)

(490)

565

Credit or payments made during the period

(6,906)

(3,427)

(264)

(10,597)

Balance at December 31, 2020

 

$

2,461

$

2,115

$

1,489

$

6,065

Chargebacks,

Government

Discounts and

and Other

Fees

Rebates

Returns

Total

Balance at January 1, 2019

    

$

623

 

$

843

$

170

$

1,636

Provision related to current period sales

5,170

2,864

99

8,133

Credit or payments made during the period

(4,500)

(1,906)

(31)

(6,437)

Balance at December 31, 2019

 

$

1,293

$

1,801

$

238

$

3,332